Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer
NCT04517266
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
214
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
RADIATION:
omit of IMI group
RADIATION:
IMI group
Sponsor
Ruijin Hospital